Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
With with GLP-1 drugs, gastrointestinal issues, such as nausea, vomiting, constipation, and gastroesophageal reflux disease, ...
A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly ...
Snack foods and sweet treats have seen a decline in purchases, as people reach for more nutrient-dense options.
A large study published in Nature Medicine reviewed the effects of GLP-1 drugs like Ozempic and Mounjaro on 175 different ...
Hims & Hers’ decision to advertise at the Super Bowl represents an ambitious play for the brand as it positions itself in the ...
If your constipation lasts for more than three days, speak with your doctor about options to help. You might need to add a ...
Explore how GLP-1 agonists, originally for diabetes, could transform addiction treatment by reducing cravings.